Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001926254-26-000002
Filing Date
2026-02-19
Accepted
2026-02-19 18:44:43
Documents
1
Period of Report
2026-02-18

Document Format Files

Seq Description Document Type Size
1 form4-02192026_110240.html 4  
1 form4-02192026_110240.xml 4 3279
  Complete submission text file 0001926254-26-000002.txt   4975
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address
Hackman Jeffrey S. (Reporting) CIK: 0001926254 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 26656045